Bruno Van Vlem

ORCID: 0000-0003-3202-4747
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dialysis and Renal Disease Management
  • Potassium and Related Disorders
  • Renal Transplantation Outcomes and Treatments
  • Metabolism and Genetic Disorders
  • Gastrointestinal motility and disorders
  • Blood Pressure and Hypertension Studies
  • Chronic Kidney Disease and Diabetes
  • Organ Transplantation Techniques and Outcomes
  • Erythropoietin and Anemia Treatment
  • Cardiovascular Health and Disease Prevention
  • Renal function and acid-base balance
  • Antibiotics Pharmacokinetics and Efficacy
  • Diet and metabolism studies
  • Atrial Fibrillation Management and Outcomes
  • Nitric Oxide and Endothelin Effects
  • Acute Kidney Injury Research
  • Magnesium in Health and Disease
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Mycobacterium research and diagnosis
  • Mitochondrial Function and Pathology
  • Hormonal Regulation and Hypertension
  • Gastroesophageal reflux and treatments
  • Neurological and metabolic disorders
  • Vitamin K Research Studies
  • Hemoglobinopathies and Related Disorders

Onze Lieve Vrouwziekenhuis Hospital
2008-2022

Pediatric Nephrology of Alabama
2019

Vilnius University
2010

Wroclaw Medical University
2010

University of Wrocław
2010

University of San Diego
2008

Ghent University Hospital
1996-2007

University of Michigan
2004

Ghent University
2000-2002

Geneeskundige en Gezondheidsdienst
2001

Hiddo J.L. Heerspink Hans‐Henrik Parving Dennis L. Andress George L. Bakris Ricardo Correa-Rotter and 95 more Fan Fan Hou Dalane W. Kitzman Donald Kohan Hirofumi Makino John J.V. McMurray Joel Z. Melnick Michael G. Miller Pablo E. Pérgola Vlado Perkovic Sheldon W. Tobe Tingting Yi Melissa Wigderson Dick de Zeeuw Alicia Elbert Augusto Vallejos Andres Alvarisqueta Laura Maffei Luis I. Juncos Javier de Arteaga Gustavo Greloni Eduardo Farias A Zucchini Daniel Vogel Ana María Cusumano Juan Carlos Santos Margaret B. Fraenkel Martin Gallagher Timothy M. E. Davis Shamasunder Acharya Duncan Cooke Michael Suranyi Simon D. Roger Nigel D. Toussaint Carol A. Pollock Doris Chan Stephen N Stranks Richard J. MacIsaac Zoltán Endre Alice Schmidt Rudolf Prager Gert Mayer Xavier Warling Michel Jadoul Jean Hougardy Chris Vercammen Bruno Van Vlem Pieter Gillard Adriana Costa e Forti João Borges Luis Santos Canani Freddy G. Eliaschewitz Silmara Leite Fadlo Fraige Filho Raphael Paschoalin José A. Moura-Neto Luciane Mônica Deboni Irene de Lourdes Noronha Cíntia Cercato Carlos Alberto Prompt Maria Teresa Zanella Nelson Rassi Domingos O. d’Avila Rosângela Milagres João Soares Felício Roberto Pécoits-Filho Miguel C. Riella João Eduardo Nunes Salles Elizete Keitel Sérgio Antônio Draibe Celso Amodeo J. T. Youmbissi Louise Roy Serge Cournoyer Shivinder Jolly Vincent Pichette Gihad Nesrallah Harpreet S. Bajaj Hasnain Khandwala Ronnie Aronson Richard Goluch Paul Kwong Hang Tam Christian Rabbat Sheldon W. Tobe G. Howard Bailey S. P. Chow A Castillo A. Vargas Fernando González Rodrigo Muñoz Vicente Gutiérrez Gonzalo Godoy Hongwen Zhao Zhangsuo Liu Ming‐Hui Zhao Xiaohui Guo

10.1016/s0140-6736(19)30772-x article EN The Lancet 2019-04-14

Significance Statement Functional vitamin K deficiency, exacerbated by the use of antagonists (VKAs), is thought to contribute rapid progression vascular calcifications in patients on dialysis. We randomized receiving chronic hemodialysis with atrial fibrillation VKAs, rivaroxaban, or rivaroxaban high-dose K2 supplements. During 18 months follow-up, status improved significantly withdrawal VKAs and supplementation. Nevertheless, changes coronary artery, thoracic aorta, cardiac valve calcium...

10.1681/asn.2019060579 article EN Journal of the American Society of Nephrology 2019-11-08

Haemodialysis patients suffer from accelerated vascular calcification. The vitamin K-dependent matrix Gla protein (MGP) is one of the most powerful inhibitors have high levels inactive form MGP (desphosphorylated-uncarboxylated-MGP, dp-uc-MGP) and may benefit pharmacological doses K2 (menaquinone) to improve calcification inhibitory activity MGP. To determine optimal dose menaquinone-7 (MK-7) for activation, 200 chronic haemodialysis were recruited randomly receive 360, 720 or 1080 µg MK-7...

10.1093/ndt/gft464 article EN Nephrology Dialysis Transplantation 2013-11-26

Preliminary evidence suggests patients on hemodialysis have a blunted early serological response to SARS-CoV-2 vaccination. Optimizing the vaccination strategy in this population requires thorough understanding of predictors and dynamics humoral cellular immune responses different vaccines.This prospective multicenter study 543 75 healthy volunteers evaluated at 4 or 5 weeks 8 9 after administration BNT162b2 mRNA-1273 vaccine, respectively. We assessed anti-SARS-CoV-2 spike antibodies T cell...

10.1681/asn.2021070908 article EN Journal of the American Society of Nephrology 2021-09-29

Abstract Background: Uremic syndrome is the consequence of retention solutes usually cleared by healthy kidneys. p-Cresol can be considered a prototypic protein-bound uremic toxin. It conceivable, analogous with drugs, that non-protein-bound fraction p-cresol exerts toxicity. This aspect had never been evaluated, nor have factors influencing free p-cresol. Methods: In transsectional study we evaluated relationship between prehemodialysis and ratio to total (F:T) clinical biological in 44...

10.1373/49.3.470 article EN Clinical Chemistry 2003-03-01

In previous studies on the effect of renal stenting arterial hypertension, patients were selected mainly basis angiographic parameters artery stenosis. The aim present study was to evaluate whether translesional pressure gradients could identify with stenosis who might benefit from stenting.A total 53 consecutive hypertensive unilateral RAS scheduled for intervention recruited. Transstenotic measured at baseline and during maximal hyperemia, before stenting. Twenty-four-hour ambulatory blood...

10.1161/circinterventions.110.957704 article EN Circulation Cardiovascular Interventions 2010-11-16

Acute renal failure after cardiac surgery increases in-hospital mortality. We evaluated the effect of intra- and postoperative tight control blood glucose levels on function based Risk, Injury, Failure, Loss, End-stage kidney (RIFLE) criteria, need for acute dialysis. retrospectively analyzed two groups consecutive patients undergoing with cardiopulmonary bypass between August 2004 June 2006. In first group, no glycemic was implemented (Control, n = 305). Insulin therapy initiated at > 150...

10.1186/cc7145 article EN cc-by Critical Care 2008-01-01

Background. Several studies with erythropoiesis-stimulating agents claim that maintenance therapy of renal anaemia may be possible at extended dosing intervals; however, few were randomized, results varied, and comparisons between absent. We report a multi-national, prospective trial comparing haemoglobin methoxy polyethylene glycol-epoetin beta darbepoetin alfa administered once monthly.

10.1093/ndt/gfq305 article EN cc-by-nc Nephrology Dialysis Transplantation 2010-06-03

Background. Extending the administration interval of erythropoiesis-stimulating agents (ESAs) represents an opportunity to improve efficiency anaemia management in patients with chronic kidney disease (CKD). However, effective haemoglobin (Hb) maintenance can be challenging epoetin alfa and beta administered at extended intervals. C.E.R.A., a continuous erythropoietin receptor activator, has unique pharmacologic profile long half-life (∼130 h), allowing Phase III results have demonstrated...

10.1093/ndt/gfn320 article EN cc-by-nc Nephrology Dialysis Transplantation 2008-06-28

In clinical practice, glomerular filtration rate (GFR) is the most important marker for evaluation of renal function (1). Dosages drugs that are eliminated by often based on GFR. At present, reliable methods accurate assessment overall GFR require intravenous administration exogenous compounds and both cumbersome expensive. creatinine clearance (CrCl) widely accepted as a simple measure However, CrCl systematically overestimates because freely filtered glomerulus also secreted proximal...

10.1373/49.6.1011 article EN Clinical Chemistry 2003-06-01
Rajiv Agarwal Jennifer B. Green Hiddo J.L. Heerspink Johannes F.E. Mann Janet B. McGill and 95 more Amy K. Mottl Julio Rosenstock Peter Rossing Muthiah Vaduganathan Meike Brinker Robert Edfors Na Li Markus F. Scheerer Charlie Scott Masaomi Nangaku Agostino Consoli Ahmed Awad Alberto Ortíz Alfonso Soto Ali Iranmanesh Amy K. Mottl An Nollet Ankur Doshi Anna Maria Veronelli Anushka Patel Ashar Luqman T Balasubramaniyan Bernhard R. Winkelmann Bruce Baker Bruno Guerci Bruno Van Vlem Bruno Vergès Byung‐Wan Lee Carolina Solis‐Herrera Chandrashekar Matad Chang Beom Lee Chien‐Te Lee Chiz‐Tzung Chang Choon Hee Chung C Kloos Christoph Axthelm Claus Bogh Juhl Cristina Castro Cristóbal Morales Csaba P. Kövesdy Daishiro Yamada Dana Mitchell David E. Gaskin D. R. Lamond Der‐Cherng Tarng Dinesh Khullar Pierre‐Louis Carron Manisha Sahay Elie Sahyouni Emanuele Bosi Enrico Fiaccadori Eun Young Lee Faiad Adawi Fernando Cereto Castro Francis Duyck Francisco Martínez Deben Francisco J. Tinahones Fumi Umeoka Ganapathi Bantwal Genya Aharon‐Hananel Germán T. Hernández Giancarlo Tonolo Giuseppe Mazza Giuseppe Penno Gloria Ortiz Guillermo E. Umpierrez Hanane Bourarich Hansraj Alva Harold L. Miller Harvey Serota Hideo Kanehara Hidetoshi Kanai Hitesh K. Mehta Idit F. Liberty Khalid Iqbal Jae Myung Yu J Probst Jacob Sandberg Jay H. Shubrook E. Jayakumar Jean‐Pierre Fauvel Jeroen van der Net Jesper Nørgaard Bech J.L. Teruel Jose Mandry Jacob M. Ravid Juan Diego Mediavilla Jugal Bihari Gupta Julie Silverstein Julio Wainstein Ju‐Ying Jiang C B Keshavamurthy Keung Lee Klaus Busch Kunihisa Kobayashi

Finerenone, a selective nonsteroidal MRA, and SGLT2is both reduce CKD progression improve kidney/CV outcomes. The CONFIDENCE study (NCT05254002; EudraCT 2021-003037-11) hypothesis is that early combination of finerenone empagliflozin, SGLT2i, superior to either drug alone in reducing UACR over 6 months. an ongoing, fully enrolled, randomized, controlled, double-blind, multicentre phase 2 clinical trial adults (≥18 years age) with T2D, eGFR 30 90 ml/min/1.73 m2, ≥100 <5000 mg/g. Participants...

10.1093/ndt/gfaf022 article EN cc-by Nephrology Dialysis Transplantation 2025-01-29

Many patients with chronic renal failure have dyspeptic symptoms. In the present study, we assessed Helicobacter pylori (Hp) status, symptoms and gastric emptying rates in uremic patients. The study was undertaken to compare not under dialysis therapy (predialysis), hemodialysis (HD) peritoneal (PD) for these variables search a possible causative role of Hp.We used standardized questionnaire assess Gastric were determined by 13C-octanoic acid breath test. HD examined outside session, PD...

10.5414/cnp57201 article EN Clinical Nephrology 2002-03-01

C.E.R.A., a continuous erythropoietin receptor activator, is long-acting erythropoiesis-stimulating agent (ESA) that approved for the treatment of renal anemia. This analysis evaluated safety profile C.E.R.A. in comparison to other ESAs patients with chronic kidney disease (CKD).Safety parameters were analyzed pooled population comprising all CKD on dialysis and not from completed Phase II III studies clinical program (Phase II/III population); treated either (n = 1,789) or comparator ESA...

10.5414/cnp73094 article EN Clinical Nephrology 2010-02-01

Introduction A delay in gastric emptying rate has been reported peritoneal dialysis patients, often normalizing after evacuation of the dialysate. To evaluate effect intraperitoneal volume, we compared this finding with a cirrhotic model which was studied before and large-volume paracentesis. Methods design We used 13C-octanoic acid breath test to measure half-emptying time (T1/2) for solids patients alcoholic cirrhosis, non-diabetic control population (asymptomatic volunteers). Cirrhotic...

10.1097/00042737-200204000-00010 article EN European Journal of Gastroenterology & Hepatology 2002-04-01

BACKGROUND:Hypomagnesemia is associated with a disturbed glucose metabolism. Insulin hypo-secretion predicts diabetes in the general population and transplant recipients. We aimed to assess whether magnesium improves insulin secretion glycemic control after transplantation prevalent hypomagnesemic kidney MATERIAL AND METHODS:We conducted an open-label, randomized, parallel-group study. Eligible participants were adults more than 4 months on tacrolimus persisting serum concentrations <1.8...

10.12659/aot.903439 article EN Annals of Transplantation 2017-08-29

Enterococcus cecorum was isolated as the etiologic agent of a continuous ambulatory peritoneal dialysis peritonitis episode in an alcoholic patient. To date, this is only third infection due to bacterium, found intestinal tract many domestic animals, that has been reported humans.

10.1128/jcm.38.9.3511-3512.2000 article EN Journal of Clinical Microbiology 2000-01-01

Currently available rat models for measuring gastric emptying are hampered by the necessity to kill animals at end of each experiment, which makes repetitive testing impossible. We have developed and validated a noninvasive test model, adapted from 13C-octanoic breath in humans, measurements rats. Male Wistar rats were trained on fixed protocol eat piece pancake doped with 1 microg acid after 12 h fasting, stay thereafter cylindrical glass cages. Breath tests performed fully automated system...

10.1046/j.1365-2982.2002.00334.x article EN Neurogastroenterology & Motility 2002-06-01

Increasing evidence indicates that lipophilic and/or protein-bound substances such as p-cresol are responsible for adverse physiological alterations in uraemic patients. To better understand the evolution of disposition renal failure and dialysis patients, it is necessary to determine its kinetic characteristics biotransformation pathways.We studied after intravenous injection compound eight rats with normal function. Urine was collected four 1 h intervals. evaluate presence metabolites,...

10.1093/ndt/gfg107 article EN Nephrology Dialysis Transplantation 2003-06-13
Coming Soon ...